A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design

Statistics in Medicine

Volumn 32, Issue 19, 2013, Pages 3290-3299

  Xu, Stanley ^a   Hambidge, Simon J ^a   Mcclure, David L ^a   Daley, Matthew F ^a   Glanz, Jason M ^a  

^a Kaiser Permanente Colorado   (United States)

Author keywords

Adverse events after vaccination; Fixed effects model; Maximum likelihood ratio test; Scan statistics; Self controlled case series

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; VACCINE;

ARTICLE; CASE STUDY; COVARIANCE; DRUG SAFETY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MASS IMMUNIZATION; MAXIMUM LIKELIHOOD METHOD; MEASLES; MUMPS; OBSERVATIONAL STUDY; PROBABILITY; PROCESS DEVELOPMENT; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RUBELLA; STATISTICAL ANALYSIS; STUDY DESIGN;

ADVERSE EVENTS AFTER VACCINATION; FIXED-EFFECTS MODEL; MAXIMUM LIKELIHOOD RATIO TEST; SCAN STATISTICS; SELF-CONTROLLED CASE SERIES;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; HUMANS; INCIDENCE; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MODELS, STATISTICAL; RISK ASSESSMENT; SEASONS; THROMBOCYTOPENIA; TIME FACTORS; VACCINES;

EID: 84880319567     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5733     Document Type: Article

References (31)

1. Glanz G, McClure D, Xu S, Hambidge S, Lee M, Kolczak M, Kleinman K, Mulloly J, France E. Comparison of four study designs for evaluating vaccine safety: retrospective cohort, case-control, risk-interval and self-controlled case series. Journal of Clinical Epidemiology 2006; 59:808-818.
2. Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, Baggs J, Weintraub ES, Belongia EA, Naleway A, Gee J, Platt R, Lieu TA. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics 2011; 127(Suppl 1):S54-S64.
3. Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011; 127(Suppl 1):S45-S53.
4. France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Archives of Pediatrics and Adolescent Medicine 2004; 158:1031-1036.
5. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R. Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121(3):e687-e692.
6. Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F. Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006; 296(16):1990-1997.
7. Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee G, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES. The safety of trivalent inactivated influenza vaccine in children ages 24 to 59 months. Archives of Pediatrics & Adolescent Medicine 2011; 165(8):749-755.
8. Xu S, Zhang L, Zeng C, Nelson J, Mullooly J, McClure D, Glanz J. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Statistics in Medicine 2011; 30:742-752. PMID: 21120820.
9. Glaz J, Balakrishnan N. Scan Statistics and Applications. Birkhäuser: Boston, 1999.
10. Glaz J, Pozdnyakov V, Wallenstein S. Scan Statistics: Methods and Applications. Springer: New York, 2009.
11. Naus J. The distribution of the size of the maximum cluster of points on the line. Journal of American Statistical Association 1965; 60:532-538.
12. Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Statistics in Medicine 1995; 14:799-810.
13. Nagarwalla N. A scan statistics with a variable window. Statistics in Medicine 1996; 15:845-850.
14. Molinari N, Bonaldi C, Daurhs JP. Multiple temporal cluster detection. Biometrics 2011; 57:577-583.
15. Kulldorff M. A spatial scan statistic. Communications in Statistics, Theory and Methods 1997; 26:1481-1496.
16. Jung I, Kulldorff M, Klassen AC. A spatial scan statistic for ordinal data. Statistics in Medicine 2007; 26:1594-1607.
17. Huang L, Kulldorff M, Gregorio D. A spatial scan statistic for survival data. Biometrics 2007; 63:109-118.
18. Kulldorff M. Tests for spatial randomness adjusting for an inhomogeneity: a general framework. Journal of the American Statistical Association 2006; 101:1289-1305.
19. Kleinman K, Abrams A, Kulldorff M, Platt R. A model-adjusted space-time scan statistic with an application to syndromic surveillance. Epidemiology and Infection 2005; 133:409-419.
20. Kulldorff M, Mostashari F, Duczmal L, Yih K, Kleinman K, Platt R. Multivariate spatial scan statistics for disease surveillance. Statistics in Medicine 2007; 26:1824-1833.
21. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126(1):e1-e8.
22. Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, Baggs J, Weintraub ES, Belongia EA, Naleway A, Gee J, Platt R, Lieu TA. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics 2011; 127(Suppl 1):S54-S64.
23. Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R. Real-time vaccine safety surveillance for the early detection of adverse events. Medical Care 2007; 45:S89-S95.
24. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51:228-235.
25. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Statistics in Medicine 2006; 25(10):1768-1797. DOI: 10.1002/sim.2302.
26. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Statistical Methods in Medical Research 2009; 18:7-26. DOI: 10.1177/0962280208092342.
27. Xu S, Zeng C, Newcomer S, Nelson J, Glanz J. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. Journal of Biometrics & Biostatistics 2012:1-5. DOI: 10.4172/2155-6180.S7-006.
28. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilar SG, Hadler SC. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997; 99(6):765-773.
29. Farrington CP, Whitaker HJ. Semiparametric analysis of case series data (with discussion). Applied Statistics 2006; 155:553-594.
30. Cucala L. A hypothesis-free multiple scan statistic with variable window. Biometrical Journal 2008; 50:299-310.
31. Zhang Z, Kulldorff M, Assunção R. Spatial scan statistics adjusted for multiple clusters. Journal of Probability and Statistics 2010; 2010:1-11.